Conference on Methodology for Clinical Trials in Small Populations and Rare Diseases
26-28 April 2017, University of Warwick, Coventry, UK
*** REMINDER: early bird registration closes 26 March 2017 ***
A rare disease is defined to be one that effects less than one in 2,000 of the general population, though many are much
less common than this, perhaps affecting only a handful of people in any country.
In such settings where numbers are scarce, the large clinical trials that are generally used to evaluate new drugs and other
healthcare interventions are infeasible or often impossible. As a result, new approaches to the design of such studies, or
improved methods of data analysis and subsequent decision-making, are needed. The InSPiRe (Innovation in Small
Populations Research) project is a three-year EU-funded project focussing on the development of novel methodology in
response to this need.
This conference will present key results from the InSPiRe project and bring together international experts in innovative
clinical trial design and analysis to present recent advances in the methodology for clinical trials in small populations. In
addition to a series of plenary invited talks, the conference will include two pre-conference courses and poster presentations.
For more information or to register, please go to http://warwick.ac.uk/inspireconference
Cost: £300* registration (before 27 March 2017);
£325* registration from 27 March 2017. Final registration closes 21 April 2017.
£50 additional cost to attend one of the courses.
*This covers the 2 1/2 day conference, including catering and a dinner on the Thursday evening.
Course fee and accommodation are not included.
Conference organising committee:
Chair: Nigel Stallard (Warwick Medical School, UK) Tim Friede (University Medical Center Göttingen, Germany)
Martin Posch (Medical University of Vienna, Austria) Sarah Zohar (INSERM, Paris, France)
The InSPiRe project has received funding from the European Union's Seventh Framework Programme for research,
technological development and demonstration under grant agreement number FP HEALTH 2013 - 602144.
You may leave the list at any time by sending the command
SIGNOFF allstat
to [log in to unmask], leaving the subject line blank.
|